Recombinant E-selectin (Novavax/NINDS)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant E-selectin (Novavax/NINDS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionStrokeIschemic Attack, Transient
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Neurological Disorders And StrokeNovavax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovavaxNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionStrokeIschemic Attack, Transient

Other Information

ATC CodeN/A
Related LinksN/A